{"id":"W6982667939","doi":"","title":"Iovance Biotherapeutics Reports Third Quarter 2017 Financial Results","year":2017,"lang":"en","type":"other","venue":"","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Payment; Term (time); Work (physics); Financial Audit","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003625661,0.001006156,0.0005739713,0.002024968,0.001235945,0.007091213,0.001143898,0.00319418,0.4097963],"category_scores_gemma":[0.00779353,0.0004175497,0.001044283,0.001085392,0.001067903,0.001637868,0.001830645,0.00339124,0.3459749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00269949,"about_ca_system_score_gemma":0.009195114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002631689,"about_ca_topic_score_gemma":0.00506092,"domain_scores_codex":[0.9967152,0.0002128516,0.0001476627,0.0002078803,0.002203546,0.0005128069],"domain_scores_gemma":[0.9931735,0.0006290847,0.0004481049,0.0005221317,0.003040329,0.00218686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001389382,0.0001615762,0.0003540631,0.0001111005,0.00001270633,0.0001174688,0.00001199015,0.0000876201,0.0005071217,0.0031556,0.9249297,0.07041211],"study_design_scores_gemma":[0.00007749997,0.00006320666,0.0006525234,0.00009976545,0.000009308696,0.0001402528,0.00002280125,0.0001900223,0.0008966043,0.001359041,0.9964804,0.000008576505],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.00169937,0.005461963,0.001405247,0.02659583,0.02359964,0.0003905396,0.006359562,0.001134092,0.9333538],"genre_scores_gemma":[0.005255029,0.003855388,0.0006910221,0.004372038,0.00450851,0.00009712519,0.004224014,0.0002914607,0.9767054],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.5902038,"threshold_uncertainty_score":0.841854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0314577210456061,"score_gpt":0.317004787028174,"score_spread":0.2855470659825678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}